Effectiveness of Meniett therapy demonstrated again
by three recent studies
Highlights of each study are as follows.
2005: Australia.
In this long-term case study, patients had their vertigo, functionality and hearing levels assessed before beginning Meniett therapy. They were evaluated again six months, 12 months, and 18 months later. For 67 percent of participants, there was significant, long-term improvement in vertigo symptoms and functionality. Twenty-seven percent also showed significant improvement in hearing. All of the patients with no improvement had undergone previous surgical or chemical treatment for the
disease.1 Learn more.
2005: Scandinavia.
In this double-blinded, randomized, placebo-controlled study, patients on Meniett therapy experienced substantially reduced vertigo symptoms and significantly improved functionality compared to patients in the control group. There was a two-month waiting period after ventilation tube insertion before treatment was begun to eliminate the possibility of symptom improvement related to the ventilation
tube.2
Learn more.
2004: United States.
This double-blinded, randomized, placebo-controlled, multicenter study showed that 70 percent of patients undergoing Meniett therapy suffered significantly less severe vertigo, fewer days with definitive vertigo and fewer days missed from work.3 Learn more.
1. Rajan, G.P., S. Din, and M.D. Atlas. 2005. Long-term effects of the Meniett device in Ménière's Disease: the Western Australian experience. J
Laryngol Otol
119:391-395.
2. Thomsen, J., K. Sass, L. Ödkvist, and S. Arlinger. 2005. Local overpressure treatment reduces vestibular symptoms in patients with Ménière's Disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
Otol Neurotol 26:68-73.
3. Gates, G.A., J.D. Green, Jr., D.L.
Tucci, and S.A. Telian. 2004. The effects of transtympanic micropressure treatment in people with unilateral Ménière's Disease.
Arch of Oto - HNS, June:130(6): 718-725.
Back to top
|
|
